Artepillin C, a specific bioactive component of BGP, was shown to decrease the activity of NF-κB and potentiate the tumor necrosis factor (TNF)-related apoptosis on LNCaP prostate cancer cells [17]. Here, TNF is linked to prostate carcinoma.